Process Development: Getting from Phase I to III.

Published on April 4, 2022

Learn how to de-risk and accelerate development by understanding the typical points in the CMC development cycle where it is important to prospectively identify where there may be knowledge gaps, and how to identify where compromises and trade-offs are in the process development approach.

The post Process Development: Getting from Phase I to III. appeared first on abzena.

Continue reading on website
Other news

Addressing the Challenges of Next-Generation Antibody-Drug Conjugate Medicines

April 4, 2022
Access and leverage deep industry knowledge into some of the key strategies in support appropriate target product profiling for the development of next-generation Antibody-Drug Conjugates (ADCs).The post Addressing the Challenges of Next-Generation Antibody-Drug Conjugate Medicines appeared first on abzena.

Advances in Downstream Intensification, Purification, and Continuous Bioprocessing.

April 4, 2022
Webinar: Louise Duffy, Chief Technical Officer at Abzena discusses how you can overcome some of your scale-up and manufacturing challenges with insights into the advances in Downstream Intensification, Purification, and Continuous Bioprocessing and the future of continuous bioprocessing. The post Advances in Downstream Intensification, Purification, and Continuous Bioprocessing. appeared first on